Statistics for Longacting cabotegravir and rilpivirine dosed every 2 months in adults with HIV1 infection ATLAS2M 48week results a randomised multicentre openlabel phase 3b noninferiority study
Total visits
| views | |
|---|---|
| Longacting cabotegravir and rilpivirine dosed every 2 months in adults with HIV1 infection ATLAS2M 48week results a randomised multicentre openlabel phase 3b noninferiority study | 3 |
Total visits per month
| views | |
|---|---|
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
File Visits
| views | |
|---|---|
| Journal.pdf | 125 |
Top country views
| views | |
|---|---|
| South Africa | 3 |
Top city views
| views | |
|---|---|
| Johannesburg | 3 |